0001209191-15-072080.txt : 20150924
0001209191-15-072080.hdr.sgml : 20150924
20150924154537
ACCESSION NUMBER: 0001209191-15-072080
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150923
FILED AS OF DATE: 20150924
DATE AS OF CHANGE: 20150924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151123083
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-23
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-09-23
4
M
0
10400
35.64
A
355684
D
Common Stock
2015-09-23
4
S
0
1000
109.09
D
354684
D
Common Stock
2015-09-23
4
S
0
1200
110.23
D
353484
D
Common Stock
2015-09-23
4
S
0
4288
111.35
D
349196
D
Common Stock
2015-09-23
4
S
0
1310
112.45
D
347886
D
Common Stock
2015-09-23
4
S
0
800
113.37
D
347086
D
Common Stock
2015-09-23
4
S
0
1300
114.58
D
345786
D
Common Stock
2015-09-23
4
S
0
502
115.34
D
345284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
35.64
2015-09-23
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
188000
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $109.09 (range $108.58 to $109.50).
Open market sales reported on this line occurred at a weighted average price of $110.23 (range $109.75 to $110.59).
Open market sales reported on this line occurred at a weighted average price of $111.35 (range $110.88 to $111.86).
Open market sales reported on this line occurred at a weighted average price of $112.45 (range $112.00 to $112.86).
Open market sales reported on this line occurred at a weighted average price of $113.37 (range $113.00 to $113.82).
Open market sales reported on this line occurred at a weighted average price of $114.58 (range $114.20 to $114.95).
Open market sales reported on this line occurred at a weighted average price of $115.34 (range $115.25 to $115.40).
Fully vested.
Omar White, Attorney-In-Fact
2015-09-24